ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,776,337, issued on Oct. 27, was assigned to IQVIA Inc. (Parsippany, N.J.).
"Method for predicting risk of relapse or onset of a psychiatric condition" was invented by Georgios Eleftheriou (San Francisco), Panagiotis Fatouros (Athens, Greece) and Charalampos Tsirmpas (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method includes, for each user in a population: audio recording the user reciting a story configured to elicit an emotion associated with a psychiatric condition; concurrently recording a set of biosignals of the user; generating a set of psychophysiological markers correlating instances of the emotion and the set of biosignals;...